Molecular imaging with dynamic contrast-enhanced computed tomography

Clinical Radiology

Volumn 65, Issue 7, 2010, Pages 549-556

  Miles, K A ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

CARDIOVASCULAR FUNCTION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; HUMAN; HYPOXEMIA; MOLECULAR IMAGING; NONHUMAN; ONCOLOGY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; STROKE; TUMOR MICROENVIRONMENT; VASODILATATION;

BLOOD VESSELS; CONTRAST MEDIA; HUMANS; MOLECULAR IMAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953297885     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2010.04.007     Document Type: Review

References (70)

1. Cenic A., Nabavi D.G., Craen R.A., et al. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 20 (1999) 63-73
2. Cenic A., Nabavi D.G., Craen R.A., et al. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 21 (2000) 462-470
3. Hattori H., Miyoshi T., Okada J., et al. Tumor blood flow measured using dynamic computed tomography. Invest Radiol 29 (1994) 873-876
4. Gillard J.H., Minhas P.S., Hayball M.P., et al. Assessment of quantitative computed tomographic cerebral perfusion imaging with H2(15)O positron emission tomography. Neurol Res 22 (2000) 457-464
5. Wintermark M., Thiran J.P., Maeder P., et al. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol 22 (2001) 905-914
6. Nabavi D.G., Cenic A., Dool J., et al. Quantitative assessment of cerebral hemodynamics using CT: stability, accuracy, and precision studies in dogs. J Comput Assist Tomogr 23 (1999) 506-515
7. Gillard J.H., Antoun N.M., Burnet N.G., et al. Reproducibility of quantitative CT perfusion imaging. Br J Radiol 74 (2001) 552-555
8. Pollard R.E., Garcia T.C., Stieger S.M., et al. Quantitative evaluation of perfusion and permeability of peripheral tumours using contrast-enhanced computed tomography. Invest Radiol 39 (2004) 340-349
9. Ng C.S., Kodama Y., Mullani N.A., et al. Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study. J Comput Assist Tomogr 33 (2009) 460-465
10. (15)O PET in patients with chronic cervical carotid artery occlusion. Neuroradiology 2008;50:745-751.
11. Miles K.A., Griffiths M.R., and Perfusion C.T. a worthwhile enhancement?. Br J Radiol 76 (2003) 220-231
12. Miles K.A. Perfusion CT for the assessment of tumour vascularity: which protocol?. Br J Radiol 76 (2003) S36-S42
13. Petralia G., Bonello L., Viotti S., et al. CT perfusion in oncology: how to do it. Cancer Imaging 10 (2010) 8-19
14. Youn S.W., Kim J.H., Weon Y.C., et al. Perfusion CT of the brain using 40-mm-wide detector and toggling table technique for initial imaging of acute stroke. AJR Am J Roentgenol 191 (2008) W120-W126
15. Blasberg R.G., and Gelovani J. Molecular-genetic imaging: a nuclear medicine-based perspective. Mol Imaging 1 (2002) 280-300
16. Hemphill III J.C., Smith W.S., Sonne D.C., et al. Relationship between brain tissue oxygen tension and CT perfusion: feasibility and initial results. AJNR Am J Neuroradiol 26 (2005) 1095-1100
17. Haider M.A., Milosevic M., Fyles A., et al. Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys 62 (2005) 1100-1107
18. Huang P.L., and Lo E.H. Genetic analysis of NOS isoforms using nNOS and eNOS knockout animals. In: Mize R.R., Dawson T.M., Dawson V.L., and Friendlander M.J. (Eds). Nitric oxide in brain development, plasticity and disease (1998), Elsevier, Amsterdam 13-26
19. Amin-Hanjani S., Stagliano N.E., Yamada M., et al. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 32 (2001) 980-986
20. Unterberg A.W., Stover A.J., Kressc B.B., et al. Edema and brain trauma. Neuroscience 129 (2004) 1021-1029
21. Murihara T., Horowitz J.R., Silver M., et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97 (1998) 99-107
22. Lin K., Kazmi K.S., Law M., et al. Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. Am J Neuroradiol 28 (2007) 1292-1298
23. Aviv R.I., d'Esterre C.D., Murphy B.D., et al. Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology 250 (2009) 867-877
24. Ford J., Miles K., Hayball M., et al. A simplified method for measurement of blood-brain barrier permeability using CT: preliminary results and the effect of RMP-7. In: Faulkner K. (Ed). Quantitative imaging in oncology (1996), British Institute of Radiology, London 1-5
25. Swensen S.J., Brown L.R., Colby T.V., et al. Lung nodule enhancement at CT: prospective findings. Radiology 201 (1996) 447-455
26. Jinzaki M., Tanimoto A., Mukai M., et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 24 (2000) 835-842
27. Tateishi U., Kusumoto M., Nishihara H., et al. Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma. Cancer 95 (2002) 835-842
28. Hayashi K., Tozaki M., Sugisaki M., et al. Dynamic multislice helical CT of ameloblastoma and odontogenic keratocyst: correlation between contrast enhancement and angiogenesis. J Comput Assist Tomogr 26 (2002) 922-926
29. Yi C.A., Lee K.S., Kim E.A., et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology 233 (2004) 191-199
30. Xie Q., Zhang J., Wu P.H., et al. Bladder transitional cell carcinoma: correlation of contrast enhancement on computed tomography with histological grade and tumour angiogenesis. Clin Radiol 60 (2005) 215-223
31. Li Z.P., Meng Q.F., Sun C.H., et al. Tumor angiogenesis and dynamic CT in colorectal carcinoma: radiologic-pathologic correlation. World J Gastroenterol 11 (2005) 1287-1291
32. Wang J.H., Min P.Q., Wang P.J., et al. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol 186 (2006) 1423-1430
33. Chen Y., Zhang J., Dai J., et al. Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom Imaging (2009 Sep 11) [Epub ahead of print]
34. Liu J., Xiong Z., Zhou H., et al. Multi-slice spiral CT pulmonary perfusion imaging and the expression of VEGF/PCNA in non-small cell lung cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban 34 (2009) 406-411
35. Bai R.J., Cheng X.G., Qu H., et al. Solitary pulmonary nodules: comparison of multi-slice computed tomography perfusion study with vascular endothelial growth factor and microvessel density. Chin Med J (Engl) 122 (2009) 541-547
36. Goh V., Halligan S., Daley F., et al. Colorectal tumor vascularity: quantitative assessment with multidetector CT-Do tumor perfusion measurements reflect angiogenesis?. Radiology 249 (2008) 510-517
37. Miles K.A., Griffiths M.R., and Fuentes M.A. Standardised perfusion value: a universal contrast enhancement scale that correlates with FDG-PET in lung cancer. Radiology 220 (2001) 548-553
38. Ng Q.S., Goh V., Milner J., et al. Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. Lancet Oncol 8 (2007) 111-118
39. Bisdas S., Rumboldt Z., Surlan-Popovic K., et al. Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements. AJNR Am J Neuroradiol 31 (2010) 576-581
40. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8 Suppl. 4 (2002) S62-S67
41. Kloska S.P., Dittrich R., Fischer T., et al. Perfusion CT in acute stroke: prediction of vessel recanalization and clinical outcome in intravenous thrombolytic therapy. Eur Radiol 17 (2007) 2491-2498
42. Fagan S.C., Hess D.C., Hohnadel E.J., et al. Targets for vascular protection after acute ischemic stroke. Stroke 35 (2004) 2220-2225
43. Moustafa R.R., and Baron J.C. Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. Br J Pharmacol 153 Suppl. 1 (2008) S44-S54
44. Swensen S.J., Viggiano R.W., Midthun D.E., et al. Lung nodule enhancement at CT: multicenter study. Radiology 214 (2000) 73-80
45. Cronin P., Dwamena B.A., Kelly A.M., et al. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology 246 (2008) 772-782
46. Comber L.A., Keith C.J., and Griffiths M. Miles KA Solitary pulmonary nodules: impact of quantitative contrast-enhanced CT on the cost-effectiveness of FDG-PET. Clin Radiol 58 (2003) 706-711
47. Goh V., Halligan S., Taylor S.A., et al. Differentiation between diverticulitis and colorectal cancer: quantitative CT perfusion measurements versus morphologic criteria-initial experience. Radiology 242 (2007) 456-462
48. Shim S.S., Lee K.S., Chung M.J., et al. Do hemodynamic studies of stage T1 lung cancer enable the prediction of hilar or mediastinal nodal metastasis?. AJR Am J Roentgenol 186 (2006) 981-988
49. Dugdale P.E., Miles K.A., Kelley B.B., et al. CT measurements of perfusion and permeability within lymphoma masses: relationship to grade, activity and chemotherapeutic response. J Comput Tomogr 23 (1999) 540-547
50. Goh V., Halligan S., Wellsted D.M., et al. Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study. Eur Radiol 19 (2009) 79-89
51. Hayano K., Shuto K., Koda K., et al. Quantitative measurement of blood flow using perfusion CT for assessing clinicopathologic features and prognosis in patients with rectal cancer. Dis Colon Rectum 52 (2009) 1624-1629
52. Hermans R., Meijerink M., Van den Bogaert W., et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 1351-1356
53. Xiong H.Q., Herbst R., Faria S.C., et al. A phase I surrogate endpoint study of SU6668 in patients with solid tumours. Invest New Drugs 22 (2004) 459-466
54. McNeel D.G., Eickhoff J., Lee F.T., et al. Phase I trial of a monoclonal antibody specific for integrin (MEDI-522) in patients with advanced malignancies, including an assessment on tumour perfusion. Clin Cancer Res 11 (2005) 7851-7860
55. Gandhi D., Chepeha D.B., Miller T., et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 27 (2006) 101-106
56. Meijerink M.R., van Cruijsen H., Hoekman K., et al. The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol 17 (2007) 1700-1713
57. Sabir A., Schor-Bardach R., Wilcox C.J., et al. Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy. AJNR Am J Roentgenol 191 (2008) 133-139
58. Petralia G., Preda L., Giugliano G., et al. Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume. J Comput Assist Tomogr 33 (2009) 552-559
59. Willet C.G., Boucher Y., di Tomaso E., et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10 (2004) 145-147
60. Wang J., Wu N., Cham M.D., et al. Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol 193 (2009) 1090-1096
61. Miles K.A. PET-CT in oncology: making the most of CT. Cancer Imaging (2008) S87-S93 (Suppl A)
62. Bisdas S., Spicer K., and Rumboldt Z. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging. AJNR Am J Neuroradiol 29 (2008) 1376-1381
63. Groves A.M., Wishart G.C., Shastry M., et al. Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT. Eur J Nucl Med Mol Imaging 36 (2009) 416-421
64. Veit-Haibach P., Treyer V., Strobel K., et al. Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT. Abdom Imaging (2009 Jul 11) [Epub ahead of print]
65. (15)O: practical considerations. Nucl Med Biol 27 (2000) 671-767
66. Miles K.A., and Williams R.E. Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging 8 (2008) 81-86
67. Aronen H.J., Pardo F.S., Kennedy D.N., et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 6 (2000) 2189-2200
68. Mankoff D.A., Dunnwald L.K., Gralow J.R., et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 43 (2002) 500-509
69. Miles K.A., Griffiths M.R., and Keith C.J. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 33 (2006) 22-28
70. Komar G., Kauhanen S., Liukko K., et al. Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness. Clin Cancer Res 15 (2009) 5511-5517